| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |